Should you buy UnitedHealth stock now?
The technical signal for UnitedHealth is currently Hold. UnitedHealth trades at $376.32 as of Oct 7, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -5.004 with rising momentum (signal: -5.922); RSI is at 46.1 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $481.72 points to 28.0% upside. This is a technical observation based on current data, not investment advice.
What is the price target for UnitedHealth stock?
The average analyst price target for UnitedHealth is $481.72. The current price is $376.32, which gives an upside of 28.0%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $433.55 and $529.89.
Is UnitedHealth a dividend stock?
Yes, UnitedHealth is a dividend stock with a dividend yield of 2.37%. The latest dividend was $2.32 per share. The latest ex-dividend date (traded without the dividend) was Sep 14, 2026. The payout ratio is 48.6%, which is considered sustainable.
When does UnitedHealth pay a dividend in 2026?
The next dividend date for UnitedHealth has not been set yet. The latest ex-dividend date (last trading day with dividend rights) was Sep 14, 2026. The latest dividend was $2.32 per share with an ex-dividend date of Sep 14, 2026. The dividend yield is 2.37%. The payout ratio of 48.6% points to a sustainable dividend with room to grow.
What is the risk of UnitedHealth stock?
UnitedHealth is rated as a stock in the risk category Balanced. the annual standard deviation is 34.5%, which classifies the stock as Balanced.
Is UnitedHealth overvalued?
No, UnitedHealth is considered undervalued based on the analyst price target (28.0% upside). UnitedHealth has the following valuation ratios: a P/E ratio of 24.3 (moderately to highly valued), a P/S ratio of 0.7, a P/B ratio of 3.4. The analyst price target suggests that the stock is undervalued by 28.0%.
Is UnitedHealth overbought?
No, UnitedHealth is not overbought. RSI is at 46.1 (neutral zone). The technical indicators show: RSI is at 46.1 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 0.0% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next UnitedHealth earnings report?
UnitedHealth reports its next earnings on October 13, 2026. The stock currently trades at $376.32. With a P/E ratio of 24.3, the market will be watching closely whether earnings meet expectations.
Is UnitedHealth shorted?
Yes, UnitedHealth is shorted with 1.6% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying UnitedHealth stock?
No, insiders are not buying UnitedHealth shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 2 sales. On a net basis, 660,910 $ worth of shares were sold. Across the last 20 reported transactions, the split is 12 purchases and 8 sales, with a net 62,476,273 $ bought. Active sellers include Conway Patrick Hugh, Charles D Baker, Baker Charles D. and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is UnitedHealth a good stock?
Based on our total score, UnitedHealth is rated as a mediocre stock with a total score of 58 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 64/100, Quality: 53/100, Momentum: 58/100. In addition: analysts see 28.0% upside to the price target; a dividend of 2.37%; technical signal: Hold. Whether UnitedHealth is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for UnitedHealth stock?
The outlook for UnitedHealth based on current data: the average analyst price target is $481.72 (+28.0%); the next earnings report is due on Oct 13, 2026, which can move the price; the P/E ratio is 24.3 (moderate). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is UnitedHealth stock moving?
UnitedHealth is stable right now. The technical indicators show: the price is close to the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can UnitedHealth go?
The average analyst price target for UnitedHealth is $481.72, which corresponds to a potential gain of 28.0% from the current price of $376.32. The stock has traded between $252.96 and $458.79 over the last 52 weeks. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can UnitedHealth fall?
The stock has traded as low as $252.96 over the last 52 weeks — that is 32.8% below the current price of $376.32. The biggest decline (drawdown) in the same period was 44.9% from high to low. Within a year, the price typically swings about ±34.5% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does UnitedHealth do?
Please share the source text you'd like me to rewrite — it looks like the content above is what I should work from, so here is the plain-English version based on it:
---
UnitedHealth Group (ticker: UNH) is a large American healthcare company. It makes money in two main ways:... The company belongs to the Healthcare sector, more specifically the Healthcare Plans industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate UnitedHealth as an investment.
Did UnitedHealth raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from UnitedHealth. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is UnitedHealth making money or losing money?
Yes, UnitedHealth is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 3.1% — which is modest. The operating margin (profit before interest and taxes) is 7.1%. At a P/E ratio of 24.3, you currently pay 24.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can UnitedHealth go bankrupt?
The bankruptcy risk of UnitedHealth is rated as moderate. Altman Z2 (a model for assessing financial distress) is 1.51 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 7 — which is strong. Debt relative to equity is 211% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does UnitedHealth have a lot of debt?
Yes, UnitedHealth has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 211%. For the healthcare sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. In healthcare, 80-150% is typical — large pharma companies carry debt for research and acquisitions. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can UnitedHealth service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 8.2x, and net debt equals 1.7 years of earnings (EBITDA).
